{"nctId":"NCT00731198","briefTitle":"Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)","startDateStruct":{"date":"2008-08"},"conditions":["ERCP","Pancreatic Diseases","Bile Duct Diseases"],"count":650,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Drotaverine hydrochloride"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Hyoscine-N-butylbromide"]}],"interventions":[{"name":"Drotaverine hydrochloride","otherNames":["No-spa"]},{"name":"Hyoscine-N-butylbromide","otherNames":["Scopolamine Butylbromide"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* All patients undergoing ERCP above the age of 18 years\n\nExclusion Criteria:\n\n* Patient with Billroth II gastrectomy\n* Known previous sphincterotomy\n* Active acute pancreatitis before ERCP\n* Ongoing acute cholangitis before ERCP\n* Hypotension (systolic blood pressure \\< 100 mmHg)\n* Second-degree and third-degree atrioventricular block\n* Heart failure\n* Glaucoma\n* Obstructive uropathy\n* Impaired renal function (serum creatinine \\> 133Î¼mol/L)\n* Pregnant or breastfeeding women","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Grades of the Number of Duodenal Contractions","description":"a duodenal motility grade was determined as follows: 0 = no motility; 1 = less than five contractions/minute; 2 = 5 to 10/minute; 3 = 11 to 15/minute; 4 = continuous.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.13","spread":"0.89"},{"groupId":"OG001","value":"1.17","spread":"0.82"}]}]}]},{"type":"SECONDARY","title":"Cannulation Time","description":null,"classes":[]},{"type":"SECONDARY","title":"Percentage of Successful Selective Cannulation","description":null,"classes":[]},{"type":"SECONDARY","title":"Frequency of Post-ERCP Complications","description":null,"classes":[]},{"type":"SECONDARY","title":"Side Effects","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":319},"commonTop":[]}}}